subthalamic gad gene therapy parkinsons disease rat model
motor abnormalities parkinsons disease pd caused alterations basal ganglia network activity including disinhibition subthalamic nucleus stn excessive activity major output nuclei using adeno-associated viral vector mediated somatic cell gene transfer expressed glutamic acid decarboxylase gad enzyme catalyzes synthesis neurotransmitter gaba excitatory glutamatergic neurons stn rats transduced neurons driven electrical stimulation produced mixed inhibitory responses associated gaba release phenotypic shift resulted strong neuroprotection nigral dopamine neurons rescue parkinsonian behavioral phenotype strategy suggests plasticity excitatory inhibitory neurotransmission mammalian brain exploited therapeutic benefit
